Related Experiment Video
Updated: Dec 10, 2025

Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis
Published on: September 7, 2022
COVID-19 infection in children and adolescents
Meena Naja1, Lucy Wedderburn1,2,3, Coziana Ciurtin1
1Centre for Adolescent Rheumatology Versus Arthritis at UCL, UCLH, GOSH and Centre for Rheumatology Research, Division of Medicine, UCL, London, UK.
Insights
COVID-19 is less common in children, often presenting as mild or asymptomatic cases, leading to underdiagnosis. While severe illness and mortality are rare, a severe inflammatory syndrome can occur, requiring careful case-by-case treatment decisions.
Area of Science:
- Pediatrics
- Infectious Diseases
- Epidemiology
Background:
- The COVID-19 pandemic has primarily impacted adults, with limited understanding of its effects on pediatric populations.
- Children represent a smaller proportion of diagnosed COVID-19 cases compared to adults, potentially due to a higher prevalence of asymptomatic or mild presentations.
Purpose of the Study:
- To review the current knowledge on the epidemiology, clinical features, and management of COVID-19 in children and adolescents.
- To highlight the characteristics of pediatric COVID-19, including prevalence, transmission, and clinical outcomes.
Main Methods:
- This study is a review of existing literature on COVID-19 in pediatric populations.
- Synthesizing data on epidemiology, clinical manifestations, and treatment strategies for pediatric COVID-19.
Main Results:
- COVID-19 prevalence is lower in children, with a significant percentage of cases being asymptomatic or mild (10-90%).
- Common symptoms include cough, fever, and sore throat; intensive care admission and mortality are infrequent.
- A rare but severe condition, pediatric multisystem inflammatory syndrome associated with COVID-19, has emerged.
Conclusions:
- Paediatric COVID-19 is generally mild and often underdiagnosed, but requires monitoring for rare severe complications.
- Supportive care is the mainstay of management; specific treatments for severe cases are considered on a case-by-case basis, ideally within clinical trials.
- Further research is essential to fully understand the disease course and optimal treatments for COVID-19 in children.
Abstract:
The COVID-19 pandemic has predominantly affected the adult population. The disease is less well-defined in children (≤18 years). This review summarises the current understanding of the epidemiology, clinical manifestations, and management of COVID-19 in children and adolescents. The prevalence of COVID-19 is significantly lower in children than adults, but paediatric disease is likely underdiagnosed as a result of the high numbers of asymptomatic or mild cases. Children are vulnerable to family cluster outbreaks, but are unlikely to be index cases within a household. Vertical transmission or breast milk transmission are yet to be proven. Between 10 and 90% of paediatric COVID-19 cases are asymptomatic. Symptomatic cases typically present with mild symptoms, including cough, fever and sore throat. Intensive care admission and mortality are rare. Paediatric multisystem inflammatory syndrome temporally associated with COVID-19 is a rare, but severe, newly emerging phenotype. At present, there is no specific treatment for COVID-19 in adults or children; management is usually supportive. For severe or critical disease, including paediatric multisystem inflammatory syndrome temporally associated with COVID-19, the decision to start antiviral or immunomodulatory therapy should be on a case-by-case basis; in the UK, this should be done within a clinical trial. Further research is needed into both the disease course and treatment of paediatric COVID-19.
More Related Videos
Related Concept Videos
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Sexually Transmitted Infections
Cognitive Development During Adolescence
Pharmacokinetics in Pediatric Patients: Drug Metabolism
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

